NovImmune's Grant

NovImmune raised a round of funding on October 15, 2012. Investors include Seventh Framework Programme.

NovImmune is a biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.…

Articles about NovImmune's Grant: